High doses of cholecalciferol alleviate the progression of hyperparathyroidism in patients with CKD Stages 3–4: Results of a 12-week double-blind, randomized, controlled study
Nephrology Dialysis Transplantation Mar 13, 2018
Westerberg PA, et al. - The effect of a substantial increase in calcidiol on mineral metabolism in patients with chronic kidney disease (CKD) was determined. Without causing hypercalcaemia or other side effects, administration of high daily doses of cholecalciferol in patients with CKD Stages 3–4 halted the progression of secondary hyperparathyroidism.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
